Vabysmo

Vabysmo (faricimab) is a prescription medication used to treat Wet macular degeneration, diabetic macular edema. An eye injection for wet AMD and diabetic macular edema that can allow longer intervals between treatments.

Blocks two proteins (VEGF-A and Ang-2) that cause leaky blood vessels and swelling in the retina.

Commonly reported side effects of Vabysmo include Eye inflammation, Floaters, Increased eye pressure, Blurred vision, and Rare serious eye infection. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Vabysmo does not carry an FDA Boxed Warning, but every prescription medicine has risks and possible interactions. Always follow your doctor's instructions and read the medication guide that comes with it.

The active ingredient in Vabysmo is faricimab, which belongs to a class of medicines known as VEGF/Ang-2 Bispecific Inhibitor (Eye Injection).

Vabysmo is manufactured by Genentech (Roche). It was first approved in 2022.

You may be able to lower the cost of Vabysmo by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.